moneyheap
CLRO · Analysis updated Nov 3, 2026, 5:01 PM ET
Why is ClearOne, Inc. (CLRO) stock moving?
CLRO is a micro-cap shell-like company with a market value of roughly $9–15 million. It has sold its legacy conferencing business and is pursuing a reverse merger with Cortigent, a Vivani Medical subsidiary. Nasdaq staff issued a delisting determination for failing the $2.5 million stockholders' equity rule. The company is seeking a hearing, which stays the delisting, but there is no assurance it will regain compliance. The merger also needs to clear Nasdaq's initial listing requirements. Price action is extremely erratic. The stock sat near $1.7–1.9 on Oct 19–22, then spiked to $3.25 on Oct 23 on heavy volume. It reached about $6 on Oct 27, fell to $3.41 on Oct 30, and rebounded about 66% to $5.65 on Nov 2 on roughly 489k shares. It is down about 13% pre-market today, near $4.91. There is no clear catalyst in the news for these moves, which look driven by speculation and thin float. Fundamentals are poor and TipRanks notes AI-model downgrades. Delisting and dilution risk remains high, so downside risk is large even though upside squeezes are possible.
News behind the analysis
- 12 Information Technology Stocks Moving In Tuesday's Pre-Market SessionCLRO fell 13.1% to $4.91 in pre-market trading, with a market value of about $15.1 million.
- 12 Information Technology Stocks Moving In Monday's Intraday SessionCLRO rose about 71% to $5.84 in Monday's regular session. Market value was about $9.1 million.
- 12 Information Technology Stocks Moving In Monday's Pre-Market SessionCLRO jumped 65.1% to $5.63 in Monday pre-market trading.
- U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.60%CLRO was among the top Nasdaq Composite performers, gaining 56.74% to close at 5.35.
- Clearone Communications (CLRO) Stock Price & AnalysisTipRanks lists the Nasdaq delisting determination and financing uncertainty as key bear points. It also notes all six of its AI models downgraded the stock as financial stress deepened.
- ClearOne Faces Nasdaq Delisting, Plans Compliance HearingNasdaq staff determined on Oct 8 to delist ClearOne after it missed the remedial actions in its compliance plan. The company plans to request a hearing, which would stay any delisting action.
- ClearOne 8-K: Notice of DelistingThe 8-K says ClearOne intends to present its plan to regain compliance with the stockholders' equity rule. It also warns there is no assurance Nasdaq will grant the hearing request or that compliance will be regained.
- ClearOne faces Nasdaq delisting risk after failing $2.5 million stockholders' equity ruleSummarizes the Nasdaq determination and the October 15 hearing-request deadline.
- ClearOne Announces Entry into Merger Agreement with Cortigent, Inc.ClearOne agreed to merge with Cortigent, a Vivani Medical subsidiary, and would be renamed Cortigent Holdings (proposed ticker CRGT). ClearOne has already divested its legacy conferencing business.
- ClearOne Inc 10-Q (June 30, 2026)Nasdaq ruled the Cortigent merger a change of control, so the combined company must meet initial listing requirements. The filing warns delisting could sharply cut liquidity and the share price.